HOXA10 | Clinical Trials Search

47 results for “HOXA10”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Expression of HOXA10 and HOXA11 in the Endometrium of Infertility Patients With an Endometrial Polyp Before and After Polypectomy

20 participants · First posted May 4, 2016

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

55 participants · First posted Jul 5, 2022

A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy

108 participants · First posted May 8, 2019

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

30 participants · First posted Mar 19, 2018

A Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC

156 participants · First posted Jul 26, 2021

Active, not recruiting

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

26 participants · First posted Feb 6, 2025

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

568 participants · First posted Sep 14, 2020

A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer

642 participants · First posted Oct 25, 2019

Not yet recruiting

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors

30 participants · First posted Jul 5, 2022

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

9 participants · First posted Jun 1, 2022

Page 1 of 4